+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-09-25Number of Pages: 170

Cardiac Surgery Instruments Market (Product Type - Vascular Forceps, Grasping Forceps, Needle Holders, Scissors, Clamps; End Use - Hospitals, Cardiology Clinics, ASCs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

Global Cardiac Surgery Instruments Market: Snapshot

The global cardiac surgery instruments market has experienced steady growth in the last few years and is likely to be ably supported in the near future by the rising prevalence of cardiac disorders in Western as well as developing Eastern economies, which is likely to drive the demand for cardiac surgical instruments at a steady rate. The prevalence of a lifestyle conducive to growth in the prevalence of cardiac disorders is likely to remain a key driver for the cardiac surgery instruments market in the coming years, while the increasing awareness in the healthcare sector about the importance of consistent product development is likely to enable steady growth of the cardiac surgery instruments market. 

The global cardiac surgery instruments market was valued at US$1,061.4 mn in 2017 and is likely to rise to US$1,412.7 mn by 2022 at a steady 5.9% CAGR. 

 

cardiac surgery instruments market

Vascular Forceps Likely to Dominate Cardiac Surgery Instruments Market

By product type, vascular forceps are likely to remain the commercially dominant segment in the global cardiac surgery instruments market in the coming years. Vascular forceps are used in a wide variety of cardiac procedures and comprise one of the most important components of cardiac surgeries in terms of patient safety, leading to a strong push for product innovation. This is likely to enable rapid growth of the vascular forceps market in the coming years, as the rising number of cardiac surgical procedures will lead to growing need for vascular forceps. The vascular forceps segment is expected to exhibit a strong 6.3% CAGR in the 2017-2022 forecast period, with the market share of the segment expected to rise from 29.6% to 30.3% over the forecast period. 

Rising Prevalence of Cardiac Disorders in Asia Pacific to Drive Demand

Despite the present dominance of North America and Europe in the global cardiac surgery instruments market, Asia Pacific except Japan and Japan are likely to emerge as important contributors to the global market in the coming years due to the rising prevalence of cardiac and other lifestyle disorders in Southeast Asian countries. The Asia Pacific except Japan market for cardiac surgery instruments is likely to rise to US$237.2 mn by 2022 at a robust CAGR of 6.2% due to the growing demand in countries such as China and India, where increasing adherence to Western lifestyles is leading to rising prevalence of cardiac diseases and thus a growing need for cardiac surgery instruments. 

North America to Retain Dominance in Global Cardiac Surgery Instruments Market

The North America cardiac surgery instruments market was valued at US$372.6 mn in 2017 and is likely to rise to US$503.1 mn by 2022 at a robust 6.2% CAGR therein. The North America market for cardiac surgery instruments is likely to benefit from the widespread incorporation of advanced cardiac surgery instruments and the constant drive for product enhancement due to strong presence of leading medical devices industry players and supportive government regulations. Europe is also a dominant force in the global cardiac surgery instruments market and is expected to reach a valuation of US$429.9 mn by 2022, but could see a decline in its global market share due to its unspectacular 5.5% CAGR. 

Competitive Dynamics

The global cardiac surgery instruments market is likely to exhibit intense competition in the coming years due to the rising commercial prospects of the market. However, strict safety regulations on the medical devices industry could hamper the growth of the cardiac surgery instruments market to some extent. Leading cardiac surgery instruments market players assessed in the report include Cardivon Surgical Inc., Medline Industries Inc., Delacroix-Chevalier, Cardinal Health Inc., Becton, Dickinson, and Company, CONMED Corporation, Teleflex Incorporated, C.R. Bard Inc., and B. Braun Melsungen AG. 

Global Cardiac Surgery Instruments Market: Overview

The global cardiac surgery instruments market report provides readers with a complete analysis of the global market through detailed assessment of the segmentation of the cardiac surgery instruments market and the market’s competitive dynamics. The global cardiac surgery instruments market has experienced steady growth in the recent past due to the growing prevalence of cardiac diseases in a number of countries across the world, making the market relevant to the healthcare sector in terms of its commercial contribution and technological scenario. The report provides a thorough assessment of the global cardiac surgery instruments market aimed at guiding readers towards profitable strategies in the market.

According to Transparency Market Research, the global cardiac surgery instruments market was valued at US$1,061.4 mn in 2017. Exhibiting a steady 5.9% CAGR, the cardiac surgery instruments market is expected to rise to US$1,412.7 mn by 2022.

Global Cardiac Surgery Instruments Market: Dynamics

The major drivers and restraints affecting the global cardiac surgery instruments market are profiled in the report in order to deliver a clear picture of which factors are likely to leave a lasting impact on the market in the coming years. The growth trajectory of the cardiac surgery instruments market is affected by a number of factors due to the close association of the cardiac healthcare sector with healthcare safety and product quality regulations. The regulatory factors affecting the global cardiac surgery instruments market are thus described in brief in the report, aiding readers in understanding the regulatory landscape likely to determine the growth prospects of the cardiac surgery instruments market in the coming years.

The detailed assessment provided in the report will help readers navigate the various pitfalls in the cardiac surgery instruments market, as the market carries a certain amount of risk due to strict healthcare regulations.

Global Cardiac Surgery Instruments Market: Segmentation

The product and end use segments of the global cardiac surgery instruments market are studied in the report to deliver readers a clear picture of the hierarchy of the market by each criterion. The leading segments in the cardiac surgery instruments market are profiled in the report and their historical figures are assessed in detail to understand how the segments are likely to develop over the coming years.

The report segments the global cardiac surgery instruments market into vascular forceps, grasping forceps, needle holders, scissors, clamps, and other instruments, and delivers 2012-2022 timelines for each product segment. Vascular forceps are likely to remain the dominant revenue generator for the global cardiac surgery instruments market in the coming years due to their widespread demand. The vascular forceps segment is expected to exhibit a strong 6.3% CAGR over the 2017-2022 forecast period to rise from US$314.6 mn to US$427.9 mn by 2022.

Geographically, North America is expected to hold on to a dominating position in the global cardiac surgery instruments market in the coming years by exhibiting a 6.2% CAGR from 2017 to 2022. The North America market is likely to rise to US$503.1 mn by 2022, followed by Europe, which is expected to reach a valuation of US$429.9 mn by 2022.

Global Cardiac Surgery Instruments Market: Competitive Dynamics

The report provides an accurate picture of the competitive landscape of the global cardiac surgery instruments by profiling each leading company and describing its role in the development of the cardiac surgery instruments in recent years. Leading cardiac surgery instruments market players assessed in the report include Cardivon Surgical Inc., Medline Industries Inc., Delacroix-Chevalier, Cardinal Health Inc., Becton, Dickinson, and Company, CONMED Corporation, Teleflex Incorporated, C.R. Bard Inc., and B. Braun Melsungen AG.


 
 
Back To Top